97
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Semi-Elective Cervical Disc Replacements for Cervical Myelopathy: A Qualitative Study

ORCID Icon & ORCID Icon
Pages 2455-2458 | Published online: 05 Nov 2021
 

Abstract

Cervical disc prolapse can be accompanied by severe pain, numbness, paraesthesiae and muscle weakness. The choice lies between a conservative approach with physiotherapy and pain modulating drugs, such as gabapentin, or a more active surgical approach, ranging from nerve decompression through vertebral foraminotomy through to cervical disc replacement. We relate the experience of a medically qualified patient in having disc prolapse at three cervical levels and what it was like to experience a lonely and difficult post-surgical recovery. Despite this, the patient would still choose active surgical decompression over a non-interventional approach. The reasons for this are discussed from the patient perspective, of which there is little directly in the medical literature.

Statement of Human and Animal Rights

All procedures undertaken in this study were in accordance with local research ethics committee protocols and with the 1975 Declaration of Helsinki on Human Rights.

Ethical Approval

The local Research Ethics Committee did not require ethical approval for the authors to speak to the patient, provided prior written, informed consent was obtained.

Statement of Informed Consent

Written informed consent was obtained from the patient for their anonymized information to be published in this article. The patient approved the final draft of the manuscript.

Acknowledgments

We thank Professor Marsha Y. Morgan for reading the manuscript and making helpful comments on language, style and content. The authors are also grateful to Dr Mark McPhail for helpful advice and suggestions.

Disclosure

The authors report no conflicts of interest.

Additional information

Funding

SDT-R is grateful to the United Kingdom National Institute for Healthcare Research at Imperial College London for infrastructure support and the Wellcome Trust Institutional Strategic Support Fund for funding (Grant number 105603/Z/1/Z).